Cargando…

Sex-based dimorphism of anticancer immune response and molecular mechanisms of immune evasion

PURPOSE: We previously demonstrated that sex influences response to immune-checkpoint inhibitors. Here we investigate sex-based differences in the molecular mechanisms of anticancer immune-response and immune evasion in patients with NSCLC. EXPERIMENTAL DESIGN: We analyzed a) transcriptome-data of 2...

Descripción completa

Detalles Bibliográficos
Autores principales:	Conforti, Fabio, Pala, Laura, Pagan, Eleonora, Bagnardi, Vincenzo, De Pas, Tommaso, Queirolo, Paola, Pennacchioli, Elisabetta, Catania, Chiara, Cocorocchio, Emilia, Ferrucci, Pier Francesco, Saponara, Maristella, Orsolini, Gianmarco, Zagami, Paola, Nicoló, Eleonora, De Marinis, Filippo, Tortora, Giampaolo, Bria, Emilio, Minucci, Saverio, Joffe, Hadine, Veronesi, Paolo, Wargo, Jennifer, Rosenthal, Rachel, Swanton, Charles, Mantovani, Alberto, Gelber, Richard D., Viale, Giuseppe, Goldhirsch, Aron, Giaccone, Giuseppe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7611463/ https://www.ncbi.nlm.nih.gov/pubmed/34016641 http://dx.doi.org/10.1158/1078-0432.CCR-21-0136

Ejemplares similares

Association of Anticancer Immune Checkpoint Inhibitors With Patient-Reported Outcomes Assessed in Randomized Clinical Trials: A Systematic Review and Meta-analysis
por: Pala, Laura, et al.
Publicado: (2022)

Evaluation of pathological complete response as surrogate endpoint in neoadjuvant randomised clinical trials of early stage breast cancer: systematic review and meta-analysis
por: Conforti, Fabio, et al.
Publicado: (2021)

EGFR-TKI Plus Anti-Angiogenic Drugs in EGFR-Mutated Non–Small Cell Lung Cancer: A Meta-Analysis of Randomized Clinical Trials
por: Conforti, Fabio, et al.
Publicado: (2020)

Sex-based differences in response to anti-PD-1 or PD-L1 treatment in patients with non-small-cell lung cancer expressing high PD-L1 levels. A systematic review and meta-analysis of randomized clinical trials
por: Conforti, F., et al.
Publicado: (2021)

Endocrine-responsive lobular carcinoma of the breast: features associated with risk of late distant recurrence
por: Conforti, Fabio, et al.
Publicado: (2019)

The rare entity of gastrointestinal leiomyosarcomas: An Italian multicenter retrospective study in high‐volume referral centers
por: Zagami, Paola, et al.
Publicado: (2023)

Tailoring the optimal duration of the extended adjuvant endocrine therapy in patients with early-stage breast cancer. A systematic review and meta-analysis of randomized clinical trials()
por: Pala, Laura, et al.
Publicado: (2023)

Data of Italian Cancer Centers from two regions with high incidence of SARS CoV-2 infection provide evidence for the successful management of patients with locally advanced and metastatic melanoma treated with immunotherapy in the era of COVID-19
por: Pala, Laura, et al.
Publicado: (2020)

Patients with locally advanced and metastatic cutaneous squamous cell carcinoma treated with immunotherapy in the era of COVID-19: stop or go? Data from five Italian referral cancer centers
por: Saponara, Maristella, et al.
Publicado: (2020)

Exon-18-EGFR Mutated Transformed Small-Cell Lung Cancer: A Case Report and Literature Review
por: Digiacomo, Nunzio, et al.
Publicado: (2023)

Anti-cytotoxic T lymphocyte antigen-4 antibodies in melanoma
por: Tosti, Giulio, et al.
Publicado: (2013)

Management of Cardiac Toxicity Induced by Chemotherapy
por: Trapani, Dario, et al.
Publicado: (2020)

Different effectiveness of anticancer immunotherapy in men and women relies on sex-dimorphism of the immune system
por: Conforti, Fabio, et al.
Publicado: (2018)

Biological and clinical features of triple negative Invasive Lobular Carcinomas of the breast. Clinical outcome and actionable molecular alterations()
por: Conforti, Fabio, et al.
Publicado: (2021)

PIK3CAMutations in Breast Cancer Subtypes Other Than HR-Positive/HER2-Negative
por: Ascione, Liliana, et al.
Publicado: (2022)

Successful treatment with avapritinib in patient with mucosal metastatic melanoma
por: Cocorocchio, Emilia, et al.
Publicado: (2020)

Immune Checkpoint Blockade in Cancer Treatment: A Double-Edged Sword Cross-Targeting the Host as an “Innocent Bystander”
por: Gelao, Lucia, et al.
Publicado: (2014)

Nodal Merkel Cell Carcinoma with Unknown Primary Site and No Distant Metastasis: A Single-Center Series
por: Fazio, Nicola, et al.
Publicado: (2022)

Case Report: Immune-Related Toxicity During Adjuvant Treatment With BRAF Plus MEK Inhibitors in a Melanoma Patient
por: Boutros, Andrea, et al.
Publicado: (2020)

Antitumor activity of sorafenib and imatinib in a patient with thymic carcinoma harboring c-KIT exon 13 missense mutation K642E
por: Catania, Chiara, et al.
Publicado: (2014)

Impact of autoimmune diseases on outcome of patients with early breast cancer
por: Criscitiello, Carmen, et al.
Publicado: (2016)

Vitamin D and the Risk of Non-Melanoma Skin Cancer: A Systematic Literature Review and Meta-Analysis on Behalf of the Italian Melanoma Intergroup
por: Caini, Saverio, et al.
Publicado: (2021)

Gene Expression Profiling of PDGFRA Mutant GIST Reveals Immune Signatures as a Specific Fingerprint of D842V Exon 18 Mutation
por: Indio, Valentina, et al.
Publicado: (2020)

Immune approaches to the treatment of breast cancer, around the corner?
por: Criscitiello, Carmen, et al.
Publicado: (2014)

Immune microenvironment profiling of gastrointestinal stromal tumors (GIST) shows gene expression patterns associated to immune checkpoint inhibitors response
por: Pantaleo, Maria A., et al.
Publicado: (2019)

Vitamin D Supplementation and Disease-Free Survival in Stage II Melanoma: A Randomized Placebo Controlled Trial
por: Johansson, Harriet, et al.
Publicado: (2021)

Talimogene Laherparepvec (T-VEC): An Intralesional Cancer Immunotherapy for Advanced Melanoma
por: Ferrucci, Pier Francesco, et al.
Publicado: (2021)

Dreaming of a New World Where Alzheimer’s Is a Treatable Disorder
por: Catania, Marcella, et al.
Publicado: (2019)

Editorial: Kidney Transplantation and Innate Immunity
por: Pontrelli, Paola, et al.
Publicado: (2020)

Omics approaches to understanding the efficacy and safety of disease-modifying treatments in multiple sclerosis
por: Lorefice, Lorena, et al.
Publicado: (2023)

Reply to Comments on: “Preventing chemotherapy-induced alopecia: a prospective clinical trial on the efficacy and safety of a scalp cooling system in early breast cancer patients treated with anthracyclines.”
por: Munzone, Elisabetta, et al.
Publicado: (2019)

The Role of Natural Killer Cells in the Immune Response in Kidney Transplantation
por: Pontrelli, Paola, et al.
Publicado: (2020)

Innate Immunity and Cell Surface Receptors in the Pathogenesis of COPD: Insights from Mouse Smoking Models
por: De Cunto, Giovanna, et al.
Publicado: (2020)

Current status of the adjuvant therapy in uterine sarcoma: A literature review
por: Rizzo, Alessandro, et al.
Publicado: (2019)

Triple negative breast cancer: Pitfalls and progress
por: Zagami, Paola, et al.
Publicado: (2022)

The rare entity of bilateral and unilateral neuroendocrine metastases to the breast: a case series and literature review
por: Zagami, Paola, et al.
Publicado: (2020)

Hallmarks of response to immune checkpoint blockade
por: Cogdill, Alexandria P, et al.
Publicado: (2017)

Iatrogenic early onset cerebral amyloid angiopathy 30 years after cerebral trauma with neurosurgery: vascular amyloid deposits are made up of both Aβ40 and Aβ42
por: Giaccone, Giorgio, et al.
Publicado: (2019)

Overcoming resistance to BRAF inhibition in BRAF-mutated metastatic melanoma
por: Spagnolo, Francesco, et al.
Publicado: (2014)

SARS-CoV-2 vaccine in patients with thymic epithelial tumours with and without active or pre-existing autoimmune disorders: Brief report of a TYME network safety analysis
por: Giugliano, Federica, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1dpbilg6dhdt8tkd40tu96qu3j